FDA recall D-0851-2021

Product

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01

Reason for recall

Failed Dissolution Specifications

Distribution

Nationwide within the United States

Key facts

Status

Terminated

Initiation date

2021-08-23

Report date

2021-10-06

Termination date

2022-09-07

Voluntary/Mandated

Voluntary: Firm initiated

Location

Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0851-2021